23Me has two programs in drug discovery, focused on immuno-oncology. They analyze existing drugs and genetic data to find similar signatures. They have a partnership with GSK and a dedicated drug discovery team. They believe in managing what you can and using therapeutics for what you can't control. The business has a profitable consumer side and a potentially explosive drug business. They're open to partnerships to manage the burn rate.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode